Status:
COMPLETED
A Comparative Study Between Laryngeal Mask Airway and Magensium Sulphate in Attenuating Systemic Stress Response During Emergence of Patients Undergoing Supratentorial Tumours.
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Mohamed, Ahmed A., M.D.
Tarek Ahmed Radwan
Conditions:
LMA Versus Mgso4 in Attenuating Stress Response During Emergence of Supratentorial Tumours Patients
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To evaluate the efficacy of replacement of ETT with LMA and administration of Magnesium sulphate at the end of the surgery in attenuating systemic stress response during emergence of patients undergoi...
Detailed Description
Rapid recovery from neuroanesthesia and early neurological examination are desirable in most cases.(1)Although, Systemic and cerebral hemodynamic changes caused by extubation and emergence from anesth...
Eligibility Criteria
Inclusion
- ASA physical status I, II.
- Ages between 18 and 60 years.
- Body mass index (BMI) \< 30.
- Elective surgery
Exclusion
- Patients have cardiovascular, pulmonary, renal, hepatic and endocrine diseases.
- Patients have any degree of disturbed conscious level.
- Ages \<18 or \>60 years.
- BMI \>30.
- Patients have history of allergy to Magnesium sulphate.
- Patients have uncontrolled hypertension during preoperative assessment.
- Patients have risk of aspiration (eg. hiatus hernia)
- Patients have difficult airway management during intubation with direct laryngoscope or time of intubation \>30 seconds.
- Failed ventilation with LMA.
- Emergency surgery.
Key Trial Info
Start Date :
January 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03406403
Start Date
January 19 2018
End Date
June 1 2018
Last Update
June 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Abdalla Mohamed
Cairo, Egypt, 11451